STOCK TITAN

MAXSMAKING INC (MAMK) Financials

MAMK
FY2025 annual
Revenue $29.2M +36.3% YoY
Net Income $2K -99.9% YoY
Free Cash Flow -$5.3M -74.8% YoY
Operating Cash Flow -$5.3M -74.0% YoY
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Oct 31, 2025 Reported Currency USD FYE October

Newest figures come from the 20-F for FY2025, filed Mar 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MAMK SEC filings page.

MAXSMAKING INC (MAMK) reported $29.2M in revenue for fiscal year 2025, up 36.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MAMK FY2025

Revenue recovered in FY2025, but margin compression and working-capital absorption pushed the business toward external financing.

In FY2025, gross margin fell to 8.9% from 18.5% even as revenue rebounded from FY2024, indicating the rebound arrived with a materially worse cost mix rather than clean operating leverage. The cash gap was concentrated in working capital: receivables and inventory expanded while operating cash flow reached -$5.3M, requiring financing inflows to support activity rather than growth being funded internally.

Operating margin collapsed from 10.3% in FY2024 to 0.4% in FY2025 while SG&A increased; the near-disappearance of operating profit shows that higher overhead compounded the gross-profit squeeze.

The current ratio improved from 2.2x to 3.1x, which signals greater reported short-term asset coverage but does not establish cash availability. Separately, the liquidity measure equaled 0.3 months of reported annual outflow, making the balance-sheet improvement more dependent on working-capital assets than the ratio alone suggests.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 41 / 100
Financial Health Score 41/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of MAXSMAKING INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
50

MAXSMAKING INC has an operating margin of 0.4%, meaning the company retains less than $1 of operating profit per $100 of revenue. This results in a moderate score of 50/100, indicating healthy but not exceptional operating efficiency. This is down from 10.3% the prior year.

Growth
52

MAXSMAKING INC's revenue surged 36.3% year-over-year to $29.2M, reflecting rapid business expansion. This strong growth earns a score of 52/100.

Leverage
3

MAXSMAKING INC has elevated debt relative to equity (D/E of 0.19), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 3/100, reflecting increased financial risk.

Liquidity
80

With a current ratio of 3.13, MAXSMAKING INC holds $3.13 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 80/100.

Cash Flow
10

MAXSMAKING INC's operations used $5.3M of cash, and capex of $57K added to the outflow, for a free cash flow shortfall of $5.3M. This results in a cash flow score of 10/100.

Returns
53

MAXSMAKING INC's ROE of 0.0% shows moderate profitability relative to equity, earning a score of 53/100. This is down from 22.8% the prior year.

Altman Z-Score Safe
16.57

MAXSMAKING INC scores 16.57, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($216.1M) relative to total liabilities ($9.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

MAXSMAKING INC passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

MAXSMAKING INC reported $2K of net income while operations used $5.3M of cash. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.

Interest Coverage At Risk
0.65x

MAXSMAKING INC earns $0.65 in operating income for every $1 of interest expense ($104K vs $159K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$122K
YoY-30.6%
QoQ-34.2%

MAXSMAKING INC held $122K in cash against $2.3M in long-term debt as of Q4 2025.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

MAMK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MAMK quarterly income statement
MetricQ4'2520-FQ2'256-KQ4'2420-F

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

MAMK Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MAMK quarterly balance sheet
MetricQ4'2520-FQ2'256-KQ4'2420-F
Total Assets$21.8M+23.6%$17.9M$17.7M
Current Assets$21.5M+31.0%$16.6M$16.5M
Cash & Equivalents$122K-30.6%$186K$176K
Short-Term Investments$0$0$0
Inventory$6.5M+147.0%$3.5M$2.6M
Accounts Receivable$9.9M+59.6%$6.0M$6.2M
Long-Term Investments$0$0$0
Total Liabilities$9.2M-1.9%$9.6M$9.4M
Current Liabilities$6.9M-6.2%$7.7M$7.4M
Non-Current Liabilities$2.3M+13.5%$1.8M$2.1M
Long-Term Debt$2.3M+10.7%$1.8M$2.1M
Total Equity$12.3M+54.5%$8.0M$8.0M
Retained Earnings$5.7M-1.4%$6.0M$5.8M

Not reported in any period shown, so not listed: Goodwill.

MAMK Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MAMK quarterly cash flow statement
MetricQ4'2520-FQ2'256-KQ4'2420-F

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

MAMK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MAMK quarterly financial ratios
MetricQ4'2520-FQ2'256-KQ4'2420-F
Current Ratio3.13+0.9x2.142.24
Debt-to-Equity0.19-0.1x0.230.26

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
MAXSMAKING INC MAMK FY2025 $29.2M $2K 0.0% $216.1M 41/100
Star Equity Holdings Inc STRR FY2025 $172.2M -$6.7M -3.9% $38.6M 41/100
Harte Hanks HHS FY2025 $159.6M -$811K -0.5% $31.9M 30/100
Planet Green PLAG FY2025 $3.0M -$27.0M N/A $10.2M 30/100
Air T AIRT FY2026 $327.1M $78.0M 23.8% $78.7M 28/100

Frequently Asked Questions

What is MAXSMAKING INC's annual revenue?

MAXSMAKING INC (MAMK) reported $29.2M in total revenue for fiscal year 2025. This represents a 36.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is MAXSMAKING INC's revenue growing?

MAXSMAKING INC (MAMK) revenue grew by 36.3% year-over-year, from $21.4M to $29.2M in fiscal year 2025.

Is MAXSMAKING INC profitable?

Yes, MAXSMAKING INC (MAMK) reported a net income of $2K in fiscal year 2025, with a net profit margin of 0.0%.

MAXSMAKING INC (MAMK) had EBITDA of $135K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, MAXSMAKING INC (MAMK) had $122K in cash and equivalents against $2.3M in long-term debt.

MAXSMAKING INC (MAMK) had a gross margin of 8.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

MAXSMAKING INC (MAMK) had an operating margin of 0.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

MAXSMAKING INC (MAMK) had a net profit margin of 0.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

MAXSMAKING INC (MAMK) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

MAXSMAKING INC (MAMK) recorded an outflow of $5.3M in free cash flow during fiscal year 2025. This represents a -74.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

MAXSMAKING INC (MAMK) recorded an outflow of $5.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

MAXSMAKING INC (MAMK) had $21.8M in total assets as of fiscal year 2025, including both current and long-term assets.

MAXSMAKING INC (MAMK) invested $57K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

MAXSMAKING INC (MAMK) invested $651K in research and development during fiscal year 2025.

MAXSMAKING INC (MAMK) had a current ratio of 3.13 as of fiscal year 2025, which is generally considered healthy.

MAXSMAKING INC (MAMK) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

MAXSMAKING INC (MAMK) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, MAXSMAKING INC (MAMK) held $122K in cash, cash equivalents and investments, and reported an operating cash outflow of $5.3M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

MAXSMAKING INC (MAMK) has an Altman Z-Score of 16.57, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

MAXSMAKING INC (MAMK) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

MAXSMAKING INC (MAMK) reported $2K of net income while operations used $5.3M of cash. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

MAXSMAKING INC (MAMK) has an interest coverage ratio of 0.65x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

MAXSMAKING INC (MAMK) scores 41 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top